Immediate Impact

1 by Nobel laureates 1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
2023 Standout
2 intermediate papers

Works of Manish Bhandari being referenced

Timing of initiation of neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+ hormone receptor (HR)-negative breast cancer: Exploratory analyses from the phase III ExteNET trial.
2018
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study
2010

Author Peers

Author Last Decade Papers Cites
Manish Bhandari 93 99 82 26 257
T. B. Quigley 96 75 73 21 312
Yang Ou 48 85 52 24 240
Paolo Bernardeschi 141 61 60 23 293
S. Sisti 51 88 62 30 324
Yuliya Linhares 91 75 66 27 273
María N. Barrachina 44 111 30 20 285
Nobuyoshi Takeuchi 69 78 64 25 308
Malvi Savani 74 57 32 18 214
Henning Schäfer 58 116 25 31 233
Simon Soudet 35 71 60 27 213

All Works

Loading papers...

Rankless by CCL
2026